(June 16, 2017, 1:05 PM EDT) -- NEW YORK — A federal judge in New York on May 31 appointed a shareholder as lead plaintiff in a consolidated securities class action lawsuit against a drug maker and certain of its current and former executive officers, ruling that the shareholder has met all statutory requirements to serve as lead plaintiff (In re Insys Therapeutics Inc. Securities Litigation, No. 17-1954, S.D. N.Y.)....